Huifeng Bio-Pharmaceutical signs supply agreement with DNP International

Under the terms of the agreement, Huifeng said that it is to deliver 62 metric tons of glucuronolactone, a naturally occurring chemical compound which has become a popular additive to energy drinks, over the next six months to DNP. The total amount of the contract is in excess of $1.1 million.

Huifeng anticipates signing additional bi-annual contracts with DNP upon successful completion of the first agreement.

Jing’An Wang, CEO of Huifeng Bio-Pharmaceutical, said: “Our agreement with DNP further demonstrates the increasing international acceptance of Huifeng products. With quality and consistency as our hallmarks, we are now becoming recognized by major US corporations for the quality and consistency of the products we develop and manufacture. We are pleased to be making further inroads into the US market and hope to sign similar supply agreements with DNP and other US entities in the near future.”